|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 11 November 2026 at 10:33pm | ||||
|
Market Cap (11-Nov) $23,079,360 (1,609th) |
Close (25-Oct) $0.048 |
Volume (25-Oct) 0 |
Shortsold (25-Jun) 3,768 (0.00%) (647th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.019 |
Investor Presentation incorporating iNKT Cell Platform
SUD released this announcement to the ASX on 18 June 2021, 12:37. The announcement is marked as price sensitive, and is 41 page(s) in length and 2.94MB in size.
You can view all announcements from SUD and see how they appear on a price chart on the announcements page.
At the date of this announcement, SUD was 0.001% short sold according to ASIC data. It was ranked the 647th most shorted stock on the ASX. It remains ranked 647th as of the latest reported data (25 June 2021).
| Other Recent Announcements from SUD | |
|---|---|
| SUDA becomes Arovella Therapeutics | 22 October 2021, 8:20 |
| Chile Ministry of Health Approval Granted for ZolpiMist | 21 October 2021, 10:00 |
| Results of General Meeting | 14 October 2021, 13:51 |
| Investor Presentation incorporating iNKT Cell Platform | 18 June 2021, 12:37 |
| SUDA Licenses a Novel iNKT Cell Therapy Platform | 18 June 2021, 10:03 |
| Trading Halt | 18 June 2021, 9:26 |
| Quarterly Appendix 4C and Activities Report | 27 April 2021, 8:21 |
If you were already registered, log in here.